Resultados de la búsqueda

Plata-Gómez AB, de Prado-Rivas L, Sanz A, Deleyto-Seldas N, García F, de la Calle Arregui C, Silva C, Caleiras E, Graña-Castro O, Piñeiro-Yáñez E, Krebs J, Leiva-Vega L, Muñoz J, Jain A, Sabio G, Efeyan A. Hepatic nutrient and hormone signaling to mTORC1 instructs the postnatal metabolic zonation of the liver. Nat Commun (2024) 15:1878
Link to the full text in Repisalud

Romero-Becera R, Santamans AM, Arcones AC, Sabio G. From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk. PHYSIOLOGY (2024) 39:98-125.

Rada P, Carceller-López E, Hitos AB, Gómez-Santos B, Fernández-Hernández C, Rey E, Pose-Utrilla J, García-Monzón C, González-Rodríguez Á, Sabio G, García A, Aspichueta P, Iglesias T, Valverde ÁM. Protein kinase D2 modulates hepatic insulin sensitivity in male mice. Mol Metabol (2024) :102045
Link to the full text in Repisalud

Herrera-Melle L, Cicuéndez B, López JA, Dumesic PA, Wilensky SE, Rodríguez E, Leiva-Vega L, Caballero A, León M, Vázquez J, Spiegelman BM, Folgueira C, Mora A, Sabio G. p38α kinase governs muscle strength through PGC1α in mice. ACTA PHYSIOL (2024) 240:e14234

Ferreira V, Folgueira C, Montes-San Lorenzo Á, Rodríguez-López A, Gonzalez-Iglesias E, Zubiaur P, Abad-Santos F, Sabio G, Rada P, Valverde ÁM. Estrogens prevent the hypothalamus-periphery crosstalk induced by olanzapine intraperitoneal treatment in female mice: Effects on brown/beige adipose tissues and liver. BBA-MOL BASIS DIS (2024) 1870:167227.

Folgueira C, Herrera-Melle L, López JA, Galvan-Alvarez V, Martin-Rincon M, Cuartero MI, García-Culebras A, Dumesic PA, Rodríguez E, Leiva-Vega L, León M, Porteiro B, Iglesias C, Torres JL, Hernández-Cosido L, Bonacasa C, Marcos M, Moro MÁ, Vázquez J, Calbet JAL, Spiegelman BM, Mora A, Sabio G. Remodeling p38 signaling in muscle controls locomotor activity via IL-15. Sci Adv (2024) 10:eadn5993

Morales-Cano D, Izquierdo-García JL, Barreira B, Esquivel-Ruiz S, Callejo M, Pandolfi R, Villa-Valverde P, Rodríguez I, Cogolludo A, Ruiz-Cabello J, Perez-Vizcaino F, Moreno L. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model. Front Pharmacol (2023) 14:1021535
Link to the full text in Repisalud

Ahmed O, Caravaca AS, Crespo M, Dai W, Liu T, Guo Q, Leiva M, Sabio G, Shavva VS, Malin SG, Olofsson PS. Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation. Bioelectron Med (2023) 9:6
Link to the full text in Repisalud

Buque X, de Urturi DS, Porteiro B, Folgueira C, Mora A, Delgado TC, Prieto-Fernandez E, Olaizola P, Santos BG, Apodaka-Biguri M, Gonzalez-Romero F, Nieva-Zuluaga A, de Gauna MR, Goikoetxea N, Rodriguez JLG, de Juan VG, Aurrekoetxea I, Montalvo-Romeral V, Novoa E, Martin-Guerrero I, Varela-Rey M, Bhanot S, Lee R, Banales JM, Syn WK, Sabio G, Martinez-Chantar ML, Nogueiras R, Aspichueta P. Methionine adenosyltransferase 1a antisense oligonucleotides induce the fibroblast growth factor 21-driven recovery from obesity and associated hepatoesteatosis J Hepatol (2022) 77:S689-S690

Rada P, Hitos AB, Rey E, Carceller-Lopez E, Pose-Utrilla J, Garcia-Monzon C, Sabio G, Iglesias T, Gonzalez A, Valverde AM. Unravelling the role of Protein Kinase D2 in the control of hepatic insulin sensitivity. J Hepatol (2022) 77:S111-S112